Compare KILITCH DRUGS with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KILITCH DRUGS vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KILITCH DRUGS SUN PHARMA KILITCH DRUGS/
SUN PHARMA
 
P/E (TTM) x 59.8 30.9 193.5% View Chart
P/BV x 2.9 4.2 70.1% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 KILITCH DRUGS   SUN PHARMA
EQUITY SHARE DATA
    KILITCH DRUGS
Mar-21
SUN PHARMA
Mar-21
KILITCH DRUGS/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs139654 21.2%   
Low Rs78339 23.1%   
Sales per share (Unadj.) Rs44.2139.6 31.7%  
Earnings per share (Unadj.) Rs2.49.5 25.5%  
Cash flow per share (Unadj.) Rs3.718.2 20.4%  
Dividends per share (Unadj.) Rs07.50 0.0%  
Avg Dividend yield %01.5 0.0%  
Book value per share (Unadj.) Rs81.8193.6 42.3%  
Shares outstanding (eoy) m15.492,399.34 0.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.53.6 69.0%   
Avg P/E ratio x44.652.1 85.6%  
P/CF ratio (eoy) x29.227.3 107.0%  
Price / Book Value ratio x1.32.6 51.7%  
Dividend payout %078.8 0.0%   
Avg Mkt Cap Rs m1,6791,190,430 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m5268,622 0.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m685334,981 0.2%  
Other income Rs m278,592 0.3%   
Total revenues Rs m712343,573 0.2%   
Gross profit Rs m5341,616 0.1%  
Depreciation Rs m2020,800 0.1%   
Interest Rs m91,414 0.6%   
Profit before tax Rs m5127,994 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m145,147 0.3%   
Profit after tax Rs m3822,847 0.2%  
Gross profit margin %7.812.4 62.4%  
Effective tax rate %26.418.4 143.7%   
Net profit margin %5.56.8 80.6%  
BALANCE SHEET DATA
Current assets Rs m804304,421 0.3%   
Current liabilities Rs m733161,456 0.5%   
Net working cap to sales %10.342.7 24.1%  
Current ratio x1.11.9 58.1%  
Inventory Days Days333149 223.3%  
Debtors Days Days1,22199 1,236.4%  
Net fixed assets Rs m1,215336,682 0.4%   
Share capital Rs m1552,399 6.5%   
"Free" reserves Rs m1,113462,229 0.2%   
Net worth Rs m1,268464,628 0.3%   
Long term debt Rs m08,981 0.0%   
Total assets Rs m2,019641,103 0.3%  
Interest coverage x6.820.8 32.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.30.5 65.0%   
Return on assets %2.33.8 60.8%  
Return on equity %3.04.9 60.4%  
Return on capital %4.76.2 76.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m18984,493 0.2%   
Fx outflow Rs m4930,334 0.2%   
Net fx Rs m14154,159 0.3%   
CASH FLOW
From Operations Rs m45761,704 0.7%  
From Investments Rs m-3765,362 -7.0%  
From Financial Activity Rs m16-59,805 -0.0%  
Net Cashflow Rs m975,964 1.6%  

Share Holding

Indian Promoters % 68.3 54.5 125.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 34.0 0.1%  
FIIs % 0.0 13.0 0.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.8 45.5 69.7%  
Shareholders   9,129 680,800 1.3%  
Pledged promoter(s) holding % 0.0 4.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KILITCH DRUGS With:   LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    CADILA HEALTHCARE    



Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KILITCH DRUGS SHARE PRICE


Jan 25, 2022 (Close)

TRACK KILITCH DRUGS

  • Track your investment in KILITCH DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

KILITCH DRUGS 5-YR ANALYSIS

COMPARE KILITCH DRUGS WITH

MARKET STATS